Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HNGE · against 173 other Healthcare companies of similar size
Ranked #128 of 174 · scores higher than 26% of peers
Bars: peers in each 10-point band of the valuation score14 peers with a valuation score of 30–39, including HNGE · Click a bar to see the companies
Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
| Metric | HNGE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 173 reported | 2.6% | 2.5% | 52% | 30% | |
| EBITDA yieldHigher is better · 173 reported | 1.1% | 4.7% | 23% | 50% | |
| Free cash flow yieldHigher is better · 105 reported | 3.0% | 2.3% | 60% | 20% | |
| Book yieldHigher is better · 172 reported | 3.7% | 19.3% | 8% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 120 | 12.6B USD | 41 | 65 | |
| 126 | 7.3B USD | 40 | 74 | |
| 126 | 62.5B SEK (≈$6.3B) | 40 | 60 | |
| 128 | 138.4B HKD (≈$17.7B) | 39 | 70 | |
| 128 | 9.4B USD | 39 | 70 | |
| 130 | 1.26T INR (≈$15.1B) | 38 | 63 | |
| 130 | 20.0B AUD (≈$13.2B) | 38 | 77 | |
| 130 | 9.1B USD | 38 | 74 | |
| 133 | 14.87T KRW (≈$10.7B) | 37 | 76 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score